Multidisciplinary Association For Psychedelic Studies
Rating: 4.89 stars 688 reviews
Location: 1215 Mission Street Santa Cruz CA 95060 USA
Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.
Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy
Geographic areas served: Worldwide
Filter Reviews by Role
Promote This Nonprofit
GreatNonprofits badges allow you to raise awareness of your favorite nonprofits on your own web sites!
10 people found this review helpful
The Multi-disciplinary Association for Psychedelic Studies is providing a valuable role in researching novel medicines to treat and heal PTSD and other serious medical issues that currently do not have effective treatment modalities. By working closely with the Federal Drug Administration MAPS has successfully conducted an important Phase 2 Study for the treatment of PTSD with MDMA. I have been affiliated with MAPS since its inception, and have watched as this organization over the years has effectively taken a humanitarian role in the approval of medicines that may assist to relieve the disease and suffering of many people who are currently without hope. I highly recommend that anyone interested in the field of research and making a donation review the website at www.maps.org.
I've personally experienced the results of this organization in...
The gratitude of the individuals who have participated in the FDA approved MDMA PTSD study.
When was your last experience with this nonprofit?